C12Y 204/01145
Alpha-1,3-mannosyl-glycoprotein 4-beta-n-acetylglucosaminyltransferase
Official title: Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase (2.4.1.145)
C12Y204/01145 (Alpha-1,3-mannosyl-glycoprotein 4-beta-n-acetylglucosaminyltransferase) appears on 1 US grants and 3 published applications in this corpus.
Search patents in C12Y- Granted patents
- 1
- Published applications
- 3
- Assignees
- 2
- Inventors
- 8
- Latest grant
- 13 Jan 2015
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
By publication year.
Recent patents
- Cell Line for Producing Recombinant Glycoproteins with Di-Antennary N-Glycans, Methods Using the Same, and Recombinant Glycoproteins5 Dec 2019US 2019/0367890 A1Cevec Pharmaceuticals GmbH
- Method to engineer mammanlian-type carbohydrate structures4 Jun 2015US 2015/0152427 A1GlycoFi, Inc.
- Method to engineer mammanlian-type carbohydrate structures4 Aug 2005US 2005/0170452 A1GlycoFi, Inc.
Most cited
By later US patents